SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intels weak fourth-quarter outlook after its earnings report, compounded by PC-market softness and analyst downgrades, is driving a steep selloff. Traders are divided between calling the drop an overreaction and buying the dip, and warning that the guidance reset and business challenges could leave more downside.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is drawing attention after a sharp selloff despite beating quarterly estimates, raising its outlook and announcing an 8-for-1 stock split. Traders are split between viewing the decline as broader tech-sector selling and an overreaction, and worrying that slowing growth and NAND pricing may signal a cyclical peak.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddits post-earnings selloff reflects concerns that declining Google search referrals, weaker-than-expected user growth, and a softer revenue outlook could pressure future growth; the planned shift toward a logged-in experience adds uncertainty about traffic and engagement. Traders are divided between viewing the drop as an overreaction to an earnings beat and seeing the traffic and user trends as a threat to the business model.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazons quarterly results put heavy AI infrastructure spending and negative free cash flow at the center of discussion, despite accelerating AWS growth. Traders are split between concerns that returns may lag and dip-buyers pointing to cloud demand, while many note the stocks rebound from its post-earnings lows.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is under pressure in a tech-wide selloff tied to Intels weak outlook and investor concerns that rising Big Tech AI spending may not deliver returns quickly enough. Traders are split between expecting further losses and treating the decline as an oversold buying opportunity.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX is drawing attention after a sharp rally and breakout, with traders speculating about a possible buyout and short covering; some connect the takeover talk to Novartiss weaker BTK results, but no deal is confirmed. Others point to upcoming earnings and BRIUMVIs growth and subcutaneous-development prospects as reasons for optimism, while debating whether the move reflects fundamentals or takeover hopes.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CRMD is under pressure after DaVitas CFO said the variable reimbursement contribution largely tied to DefenCath is expected to fall significantly after Q1 2027 and remain low or decline, fueling concern about the products commercial outlook. Traders debate whether DaVitas preliminary modeling signals weaker DefenCath economics or may be offset by utilization and updated payments; some also point to retrospective Fresenius data that found no significant difference versus ClearGuard.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Weak Intel guidance and PC demand, alongside broader tech-earnings and AI-spending concerns, have pressured semiconductor shares and amplified losses in SOXLs 3x leveraged exposure. Traders are split between buying the dip and expecting a rebound versus warning that the selloff may continue.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is drawing attention after a reported major Binance security breach sparked a crypto selloff and raised concerns about exchange security and possible forced selling. Traders are divided between seeing the drop as an overreaction and buying opportunityoften noting the exchange, not Bitcoins protocol, was compromisedand warning that losses and broader risk-off pressure could bring further downside.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Reports of Marvell being in advanced talks to acquire Lumentum are driving attention, with traders concerned that the large deal could require substantial share dilution or debt. The strategic fit in AI data-center optics draws some long-term support, but the talks remain unconfirmed and many view the potential cost as a near-term risk.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are DXLG, LAB, FHB, RLYB Obtaining Fair Deals for their Shareholders?

Are DXLG, LAB, FHB, RLYB Obtaining Fair Deals for their Shareholders? Are DXLG, LAB, FHB, RLYB Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, July 21, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--NCSM, PSBQ, LAB, and RLYB

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--NCSM, PSBQ, LAB, and RLYB $HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--NCSM, PSBQ, LAB, and RLYB PR Newswire NEW YORK, July 20, 2026 NEW YORK, July 20, 2026 /PRNewswire...

Are SUNE, RLYB, ASRT, TMHC Obtaining Fair Deals for their Shareholders?

Are SUNE, RLYB, ASRT, TMHC Obtaining Fair Deals for their Shareholders? Are SUNE, RLYB, ASRT, TMHC Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 9, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

RLYB Stock Alert: Halper Sadeh LLC is Investigating Whether Rallybio Corporation is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Rallybio Corporation (NASDAQ: RLYB) and Avenzo Therapeutics, Inc. Upon closing of the proposed transaction, Rallybio shareholders are expected to own approximately 2.8% of the combined company.Halper Sadeh encourages...

RLYB Stock Hits 2-Year Highs After Unveiling Merger With Avenzo – How Much Of The New Company Will Rallybio Shareholders Own?

Equity

Rallybio announced a merger agreement with Avenzo Therapeutics to create a publicly traded, oncology-focused biotechnology company.

Rallybio Corporation and Avenzo Therapeutics Announce Merger Agreement to Advance Next-Generation Oncology Therapies and $215 Million Concurrent Private Placement

Rallybio Corporation (Nasdaq: RLYB) ("Rallybio") and Avenzo Therapeutics, Inc. ("Avenzo"), a clinical-stage biotechnology company developing next-generation oncology therapies, today announced that they have entered into a definitive agreement pursuant to which Rallybio will acquire Avenzo through...

Rallybio (RLYB) Projected to Post Quarterly Earnings on Tuesday

Rallybio (NASDAQ:RLYB) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at...

Best Biotech Stocks To Research - May 4th

Celcuity, Danaher, Vertex Pharmaceuticals, Rallybio, and Moderna are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies focused on developing biological products, drugs, diagnostics, or platform technologies...

Institutional Giants Are Piling into Four of These NASDAQ Plays

The market is currently seeing a flurry of activity as companies across the biotech and technology sectors secure substantial funding and execute strategic transformations. $CNSP, $KBLB, $PN, $RLYB, $ADVB, $CLNN, $CABA

Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders?

Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders? Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, April 9, 2026 Insiders may stand to...

Rallybio Corp. engages in the identification, research and development, and manufacture of clinical biotechnology products and therapies for severe and rare diseases. Its product candidates focus on the areas of fetal and neonatal disorders, hematology, immuno-inflammation, and metabolic disease. The company was founded by Martin W. Mackay, Stephen Uden, and Jeffrey M. Fryer in January 2018 and is headquartered in New Haven, CT.

Rallybio Corp

Neutral Sentiment

<ul class="summary-bullets"><li>The combined company will operate under the name Avenzo Therapeutics and is expected to trade on Nasdaq under the ticker symbol AVZO.</li><li>Avenzo secured $215 million in private placement financing from Vivo Capital, Lilly Asia Ventures, and Blackstone Multi-Asset Investing, among others.</li><li>Last month, Candid Therapeutics terminated a merger deal with RallyBio to pursue an agreement with UCB.</li></ul>Shares of Rallybio Corp. (RLYB) surged more than 20% on Monday, reaching their highest level in over two years, after the biotech firm unveiled a merger with Avenzo Therapeutics, a deal that enhances its portfolio of next-generation cancer treatments and adds a substantial cash runway.This comes less than a month after Candid Therapeutics terminated a merger deal with RallyBio to pursue an agreement with UCB. The two firms had signed an agreement in March 2026.<h2 class="st-heading-2">Combined Firm To Trade Under AVZO Ticker</h2>The combined company will operate under the name Avenzo Therapeutics and is expected to trade on Nasdaq under the ticker symbol AVZO. The transaction is expected to close in the fourth quarter of 2026.Avenzo secured a $215 million in private placement financing from a group of healthcare-focused institutional investors, including Vivo Capital, Lilly Asia Ventures, and Blackstone Multi-Asset Investing, among others.The company said the proceeds are expected to fund operations into late 2028 and support several upcoming clinical milestones.Following the deal, existing Avenzo shareholders are expected to own about 97.2% of the combined company, while Rallybio shareholders will hold roughly 2.8%.<h2 class="st-heading-2">Combining Forces In Oncology</h2>Avenzo brings a portfolio of four clinical-stage oncology programs, including targeted small molecules and antibody-drug conjugates (ADCs) for the treatment of tumors. Its lead candidates include AVZO-021 and AVZO-023 for breast cancer, along with AVZO-1418 and AVZO-103, which are being studied across multiple tumor types.Meanwhile, Rallybio develops treatments for rare and serious diseases. Its pipeline includes therapies targeting conditions with limited treatment options, particularly in blood disorders and diseases linked to immune system dysfunction.<h2 class="st-heading-2">RLYB Sentiment Remains Bearish</h2>Despite the sharp rally, retail sentiment for <a href="https://stocktwits.com/symbol/RLYB">RLYB</a> on Stocktwits trended in the ‘bearish’ territory over the past 24 hours.One user said, despite the share price spike, there are “lots of issues.”<stembedurl>https://stocktwits.com/TA_Kongen/message/654947336</stembedurl>The stock has ripped 230% so far this year.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/oncy-stock-gains-on-lead-therapy-promise/cZ0gw0DReHv">ONCY Stock Heads For Sixth Straight Session Of Gains – Lead Therapy Shines in Early Combination Treatment Study</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

On Monday, Deutsche Bank said CAR’s downgrade to ‘Hold’ from ‘Buy' is "purely fundamental in nature"

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$15.85
Prev Close	$15.41
Open	$15.60
Dividend Yield	0.00%
50-Day Moving Average	$16.76
Beta	1.33
Avg. Volume	10,731.02
PE Ratio	3.43

52-Week High	$17.57
52-Week Low	$3.67
Market Capitalization	$82.97M
EPS (Annual)	-$1.59
Price to Book	0.89
Revenue Per Employee	$61,285.71

Feed

News

Sentiment

Earnings

Fundamentals

Info

RLYB Fundamentals